U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill
Go back to U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill| Merck & Co. (NYSE: MRK) | Delayed: 115.33 +1.46 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.87 | 52 Week High | $65.46 | |||
| Open | $113.97 | 52 Week Low | $47.97 | |||
| Day High | $115.56 | P/E | 78.46 | |||
| Day Low | $113.00 | EPS | $1.47 | |||
| Volume | 3,573,537 | |||||
